PANDAR and gastric cancer: Notably, multiple clinical studies have corroborated that PANDAR exhibits significant clinical relevance in GC: In 2018, Gao S et al. conducted a meta-analysis involving over 6,000 GC patients and 51 lncRNAs from various articles.